Back
Akari Therapeutics PLC Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
AKTX
Akari Therapeutics PLC
Last Price:
1.28
Seasonality Move:
-8.33%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing selling pressure, which indicates risk of future bearish movement.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.06 | Sell |
| 20-day SMA: | 2.28 | Sell |
| 50-day SMA: | 2.66 | Sell |
| 200-day SMA: | 2.54 | Sell |
| 8-day EMA: | 1.97 | Sell |
| 20-day EMA: | 2.23 | Sell |
| 50-day EMA: | 2.57 | Sell |
| 200-day EMA: | 2.95 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 27.4 | Sell |
| Chaikin Money Flow: | -77561 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.02 - 2.54) | Sell |
| Bollinger Bands (100): | (2.52 - 3.72) | Sell |
Akari Therapeutics PLC Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 1.47 while AKTX 8-day simple moving average is 2.06, which is a Sell signal.
- The stock price of AKTX is 1.47 while Akari Therapeutics PLC 20-day SMA is 2.28, which makes it a Sell.
- Akari Therapeutics PLC 50-day simple moving average is 2.66 while AKTX share price is 1.47, making it a Sell technically.
- AKTX stock price is 1.47 and Akari Therapeutics PLC 200-day simple moving average is 2.54, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
10
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a Sell
The current Akari Therapeutics PLC [AKTX] share price is $1.47. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
17.57M
Price in USD:
1.47
Share Volume:
85.32K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
1.08
Sell
10
Akari Therapeutics PLC (AKTX)
is a Sell
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?
The Akari Therapeutics PLC stock price is 1.47 USD today. -
Will AKTX stock go up or go down?
Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Akari Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is overvalued.
Is Akari Therapeutics PLC Stock a Buy?
- Akari Therapeutics PLC share price is 1.47 while AKTX 8-day exponential moving average is 1.97, which is a Sell signal.
- The stock price of AKTX is 1.47 while Akari Therapeutics PLC 20-day EMA is 2.23, which makes it a Sell.
- Akari Therapeutics PLC 50-day exponential moving average is 2.57 while AKTX share price is 1.47, making it a Sell technically.
- AKTX stock price is 1.47 and Akari Therapeutics PLC 200-day simple moving average is 2.95, creating a Sell signal.
Fundamental Analysis of Akari Therapeutics PLC
Is Akari Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
- AKTX Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Akari Therapeutics PLC is a Sell
- Akari Therapeutics PLC Relative Strength Index (RSI) is 27.4, which suggest Akari Therapeutics PLC is oversold
- The Bollinger Bands (25) for Akari Therapeutics PLC is (2.02 - 2.54), which suggest Akari Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Akari Therapeutics PLC is (2.52 - 3.72), which suggest Akari Therapeutics PLC is a Sell
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.